| Product Name | Research Grade Erfonrilimab |
|---|---|
| Target | CD152, Cytotoxic T-lymphocyte protein 4, CTLA-4, CTLA4, Cytotoxic T-lymphocyte-associated antigen 4, B7-H1, Programmed cell death 1 ligand 1, PDCD1 ligand 1, PDCD1L1, B7 homolog 1, PDCD1LG1, PDL1, hPD-L1, Programmed death ligand 1, B7H1, PD-L1, CD274 |
| source | Humanized |
| Clonality | Monoclonal |
| Isotype | Single Domains (VH-VH'-CH), IgG1na;na |
| Reactivity | Human |
| Endotoxin | Please contact the lab for this information. |
| Purification | Protein A/G purified from cell culture supernatant. |
| Purity | >95% purity as determined by SDS-PAGE. |
| Application | ELISA, Bioactivity: FACS, Functional assay, Research in vivo |
| Form | Liquid |
| Formulation | 0.01M PBS, pH 7.4. |
| Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C. |
